ABERCROMBIE & FITCH CO /DE/
For the period ended Nov 1, 2025. Filed Dec 5, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Nov 1, 2025 · Filed Dec 5, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unregistered Sales of Equity Securities and Use of Proceeds
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
There were no sales of equity securities during the third quarter of Fiscal 2025 that were not registered under the Securities Act of 1933, as amended.
The following table provides information regarding the purchase of shares of Common Stock made by or on behalf of A&F or any “affiliated purchaser” as defined in Rule 10b-18(a)(3) under the Exchange Act during each fiscal month of the thirteen weeks ended November 1, 2025:
| Period (fiscal month) | Total Number of Shares Purchased (1) | Average Price Paid per Share(4) | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (2) | Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs (2)(3)(4) |
|---|---|---|---|---|
| August 3, 2025 through August 30, 2025 | 456 | $93.82 | — | $1,050,048,833 |
| August 31, 2025 through October 4, 2025 | 436,264 | 89.40 | 423,334 | 1,012,283,449 |
| October 5, 2025 through November 1, 2025 | 827,361 | 75.28 | 826,341 | 950,067,646 |
| Total | 1,264,081 | 80.16 | 1,249,675 | 950,067,646 |
(1)An aggregate of 14,406 shares of Common Stock purchased during the thirteen weeks ended November 1, 2025 were withheld for tax payments due upon the vesting of employee restricted stock units.
(2)On March 5, 2025, the Company announced that the Board of Directors approved a new $1.3 billion share repurchase program (the “2025 Authorization”), replacing the prior share repurchase authorization of $500 million, approved by the Board of Directors in 2021 (the “2021 Authorization”). The 2025 Authorization does not have an expiration date.
(3)The number shown represents, as of the end of each period, the approximate dollar value of Common Stock that may yet be purchased under the 2025 Authorization described in footnote 2 above. The shares may be purchased, from time to time depending on business and market conditions. The 2025 Authorization replaced the 2021 Authorization and shares may no longer be repurchased pursuant to the 2021 Authorization.
(4)The aggregate cost of share repurchases and average price paid per share excludes commissions and excise tax.
| Abercrombie & Fitch Co. | 42 | 2025 3Q Form 10-Q |
|---|
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.